151 related articles for article (PubMed ID: 34728175)
1. Linear Polyglycerol for N-terminal-selective Modification of Interleukin-4.
Tully M; Hauptstein N; Licha K; Meinel L; Lühmann T; Haag R
J Pharm Sci; 2022 Jun; 111(6):1642-1651. PubMed ID: 34728175
[TBL] [Abstract][Full Text] [Related]
2. Prolonged activity of exenatide: Detailed comparison of Site-specific linear polyglycerol- and poly(ethylene glycol)-conjugates.
Tully M; Wedepohl S; Kutifa D; Weise C; Licha K; Schirner M; Haag R
Eur J Pharm Biopharm; 2021 Jul; 164():105-113. PubMed ID: 33957224
[TBL] [Abstract][Full Text] [Related]
3. Polyglycerol for Half-Life Extension of Proteins-Alternative to PEGylation?
Tully M; Dimde M; Weise C; Pouyan P; Licha K; Schirner M; Haag R
Biomacromolecules; 2021 Apr; 22(4):1406-1416. PubMed ID: 33792290
[TBL] [Abstract][Full Text] [Related]
4. Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOx.
Hauptstein N; Pouyan P; Kehrein J; Dirauf M; Driessen MD; Raschig M; Licha K; Gottschaldt M; Schubert US; Haag R; Meinel L; Sotriffer C; Lühmann T
Biomacromolecules; 2021 Nov; 22(11):4521-4534. PubMed ID: 34643378
[TBL] [Abstract][Full Text] [Related]
5. One to one comparison of cell-free synthesized erythropoietin conjugates modified with linear polyglycerol and polyethylene glycol.
Pouyan P; Zemella A; Schloßhauer JL; Walter RM; Haag R; Kubick S
Sci Rep; 2023 Apr; 13(1):6394. PubMed ID: 37076514
[TBL] [Abstract][Full Text] [Related]
6. Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2a.
Hauptstein N; Pouyan P; Wittwer K; Cinar G; Scherf-Clavel O; Raschig M; Licha K; Lühmann T; Nischang I; Schubert US; Pfaller CK; Haag R; Meinel L
J Control Release; 2022 Aug; 348():881-892. PubMed ID: 35764249
[TBL] [Abstract][Full Text] [Related]
7. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution.
Imran ul-haq M; Lai BF; Chapanian R; Kizhakkedathu JN
Biomaterials; 2012 Dec; 33(35):9135-47. PubMed ID: 23020861
[TBL] [Abstract][Full Text] [Related]
8. Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells.
Chapanian R; Constantinescu I; Rossi NA; Medvedev N; Brooks DE; Scott MD; Kizhakkedathu JN
Biomaterials; 2012 Nov; 33(31):7871-83. PubMed ID: 22840223
[TBL] [Abstract][Full Text] [Related]
9. Linear poly(methyl glycerol) and linear polyglycerol as potent protein and cell resistant alternatives to poly(ethylene glycol).
Weinhart M; Grunwald I; Wyszogrodzka M; Gaetjen L; Hartwig A; Haag R
Chem Asian J; 2010 Sep; 5(9):1992-2000. PubMed ID: 20602410
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.
Pethő L; Kasza G; Lajkó E; Láng O; Kőhidai L; Iván B; Mező G
Soft Matter; 2020 Jun; 16(24):5759-5769. PubMed ID: 32530018
[TBL] [Abstract][Full Text] [Related]
11. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
12. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
13. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol)-conjugated human serum albumin including iron porphyrins: surface modification improves the O2-transporting ability.
Huang Y; Komatsu T; Wang RM; Nakagawa A; Tsuchida E
Bioconjug Chem; 2006; 17(2):393-8. PubMed ID: 16536471
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and noncovalent protein conjugation of linear-hyperbranched PEG-poly(glycerol) alpha,omega(n)-telechelics.
Wurm F; Klos J; Räder HJ; Frey H
J Am Chem Soc; 2009 Jun; 131(23):7954-5. PubMed ID: 19462953
[TBL] [Abstract][Full Text] [Related]
16. Protein-polymer conjugation-moving beyond PEGylation.
Qi Y; Chilkoti A
Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
[TBL] [Abstract][Full Text] [Related]
17. Beyond poly(ethylene glycol): linear polyglycerol as a multifunctional polyether for biomedical and pharmaceutical applications.
Thomas A; Müller SS; Frey H
Biomacromolecules; 2014 Jun; 15(6):1935-54. PubMed ID: 24813747
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled monothiol-terminated hyperbranched polyglycerols on a gold surface: a comparative study on the structure, morphology, and protein adsorption characteristics with linear poly(ethylene glycol)s.
J Yeh PY; Kainthan RK; Zou Y; Chiao M; Kizhakkedathu JN
Langmuir; 2008 May; 24(9):4907-16. PubMed ID: 18361531
[TBL] [Abstract][Full Text] [Related]
19. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds.
Lee LS; Conover C; Shi C; Whitlow M; Filpula D
Bioconjug Chem; 1999; 10(6):973-81. PubMed ID: 10563766
[TBL] [Abstract][Full Text] [Related]
20. Poly(Oxanorbornene)-Protein Conjugates Prepared by Grafting-to ROMP as Alternatives for PEG.
Davis E; Caparco AA; Steinmetz NF; Pokorski JK
Macromol Biosci; 2024 Feb; 24(2):e2300255. PubMed ID: 37688508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
